![Keith Vendola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Vendola
Directeur Financier/CFO chez
NERVGEN PHARMA CORP.
Fortune : - $ au 30/06/2026
Profil
Keith A. Vendola is currently Chief Financial Officer at NervGen Pharma Corp.
Former positions include Senior Director-Business Development at Threshold Pharmaceuticals, Inc., Chief Financial Officer at Wugen, Inc., Head-Corporate Development at DiObex, Inc., Vice President-Finance & Corporate Development at Eiger BioPharmaceuticals, Inc., Chief of Staff & VP-Competitive Strategy at Coherus Oncology, Inc. from 2015 to 2017, Chief Strategy Officer at Rezolute, Inc. from 2020 to 2021, and Chief Financial Officer at IO Biotech, Inc. from 2021 to 2022.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from Dartmouth Medical School, and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 27/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Keith Vendola
| Sociétés | Poste | Début |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur Financier/CFO | 27/04/2026 |
Anciens postes connus de Keith Vendola
| Sociétés | Poste | Fin |
|---|---|---|
| IO BIOTECH, INC. | Directeur Financier/CFO | 09/05/2022 |
| REZOLUTE, INC. | Directeur Financier/CFO | 06/11/2020 |
| COHERUS ONCOLOGY, INC. | Responsable des Ressources Humaines | 01/06/2017 |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Directeur Financier/CFO | - |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur Financier/CFO | - |
Formation de Keith Vendola
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Technology Services |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
